Phase I Dose Escalation of Velcade (Bortezomib) Daily Dose in Patients With Advances or Metastatic Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 08 Jul 2017
At a glance
- Drugs Bortezomib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Acronyms VELDAY
- 30 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 22 Aug 2014 New trial record
- 03 Jun 2014 Interim results (n=18) presented at the 50th Annual Meeting of the American Society of Clinical Oncology.